Dania Therapeutics ApS (Dania Tx)

https://cvrapi.dk/virksomhed/dk/dania-therapeutics-aps/42523925

The company is based on research from renowned professor Kristian Helin and dr. Karl Agger originating from Helin's former research group at the University of Copenhagen. The ambition is to develop a treatment for acute myeloid leukaemia, which also holds potential for treatment of other types of cancer. *

	Start	2021-07-01 established (s-off)
	Predecessor	University of Copenhagen
	Industry	cancer drug
	Industry 2	drug development

	Region	Hellerup
	Country	Denmark
	Street	36 Sundvænget c/o Hannibal Innovation ApS
	City	2900 Hellerup
		Address record changed: 2023-10-18

Basic data	Employees	n. a.

		* Document for »About Section«: Lundbeckfonden. (10/16/23). "Press Release: Venture Forces Invest Millions in New Type of Treatment for Particularly Aggressive Form of Cancer".

		Record changed: 2024-02-12

Picture EBD Group Biotech Showcase 2025 San Francisco BTS25 650x200px

More documents for Dania Therapeutics ApS (Dania Tx)

[1] Lundbeckfonden. (10/16/23). "Press Release: Venture Forces Invest Millions in New Type of Treatment for Particularly Aggressive Form of Cancer"....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]